COWEN AND COMPANY, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 120 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$330,000
+432.3%
53,900
+107.3%
0.02%
+433.3%
Q2 2021$62,000
-80.9%
26,000
-63.3%
0.00%
-87.0%
Q1 2021$325,000
+10.5%
70,776
-20.7%
0.02%
-11.5%
Q4 2020$294,000
+14.8%
89,200
+187.7%
0.03%
+18.2%
Q4 2019$256,00031,0000.02%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders